Associate Professor Nail Paksoy is a highly active researcher in chemotherapy, serving as a sub-investigator for major trials with ROCHE, Pfizer, and AstraZeneca.

• Holds European Board Certification in Medical Oncology (ESMO), a gold standard in cancer care
• Specialises in managing chemotherapy-induced complications like thrombocytopenia
• Expert in carboplatin desensitisation protocols for patients with ovarian carcinoma
• Focuses on advanced treatments for lung, breast, and gastrointestinal cancers
• Published extensive real-world data on chemotherapy effectiveness for rare sarcomas

Professor Mustafa Serkan Alemdar is a dual-specialised medical oncologist and internal medicine expert at the JCI-accredited Medical Park Antalya Hospital Complex.

• Specialised in medical oncology at Akdeniz University Faculty of Medicine
• Managed complex cases at Antalya Training and Research Hospital
• Treats a wide range of solid tumours with personalised chemotherapy protocols
• Focuses on evidence-based medicine within a multidisciplinary oncology team
• Experienced in balancing high-intensity treatments with patient symptom management

Dr Ercan Ozden completed his medical oncology subspecialisation at Kocaeli University following a thorough double-specialisation track. He treats patients at VM Medical Park Pendik Hospital with a focus on evidence-based chemotherapy protocols.

• Trained at Istanbul University Cerrahpasa Faculty of Medicine in the competitive English Medical Program
• Completed five years of specialist training in Internal Medicine before pursuing oncology
• Gained experience in high-volume medical oncology at Sirnak State Hospital
• Focuses on managing complex chemotherapy regimes for various cancer types

Professor Irfan Cicin is a senior medical oncologist who leads complex chemotherapy programmes at İstinye University Liv Hospital Topkapı.

• Held the rank of Professor of Medical Oncology at Trakya University Faculty of Medicine since 2015
• Trained at Istanbul University Cerrahpaşa – one of Turkey's most prestigious medical institutions
• Specialises in designing personalised internal medicine protocols for diverse tumour types
• Served as Associate Professor for five years training the next generation of cancer specialists

Associate Professor Tarik Salman brings high-level expertise from top international institutions, including research and clinical roles at Moffitt Cancer Center and Memorial Sloan Kettering Cancer Center in the USA.

• Specialises in comprehensive genomic profiling to create individualised treatment plans
• Uses targeted therapies and immunotherapy alongside standard chemotherapy protocols
• Active board member of the Geriatric Oncology Association and Mediterranean Oncology Association
• Member of the American Society of Clinical Oncology since 2008
• Expert in managing rare cancers and clinical research cases

Associate Professor Muhammed Mustafa Atci is a leading medical oncologist at İstinye University Liv Hospital Topkapı, where he serves as an education coordinator for future specialists.

• Recognised for his clinical research on triple-negative breast cancer and adjuvant chemotherapy protocols
• Specialises in treating colon and lung cancers using evidence-based chemotherapy programmes
• Member of the American Society of Clinical Oncology (ASCO) since 2018
• Published extensive research on BRCA mutation profiles and hereditary cancer risks
• Expert in managing chemotherapy outcomes for elderly patients and those with complex comorbidities

Associate Professor Mehmet Salih Iyikesici specialises in metabolically supported chemotherapy to help patients manage treatment more effectively. He practices at Central Hospital, focusing on personalised protocols for complex cases.

• Provides metabolically supported chemotherapy (MSCT) for gastrointestinal and lung cancers
• Uses hyperthermia and hyperbaric oxygen therapy alongside standard treatments
• Focuses on ketogenic diet integration to support cancer metabolism management
• Published research on rectal and breast cancer treatment outcomes
• Contributes to international oncology studies on innovative therapy approaches

Associate Professor Murat Ayhan is a leading medical oncologist at Liv Hospital Vadistanbul, specialising in advanced drug therapies and precision medicine for complex cancers.

• International investigator for Phase III trials involving targeted therapies for metastatic breast cancer
• Published expert in managing chemotherapy side effects and drug desensitisation techniques
• Member of the European Society of Medical Oncology (ESMO)
• Author of a professional medical manual on common clinical chemotherapy regimens
• Specialised focus on immunotherapy and 'smart' drug protocols for lung and colorectal cancers

Professor Hilmi Apak led the Paediatric Haematology-Oncology Division at Istanbul University for over two decades and now brings his expertise to Biruni University Hospital.

• Specialises in chemotherapy for leukaemia and bone marrow transplantation
• Served as Head of the Department of Paediatrics at Istanbul University
• Published 75 papers in international medical journals regarding childhood blood disorders
• Provides advanced treatments including CAR T-cell therapy for complex cases
• Board member of the Turkish Paediatric Society and the Turkish Adolescent Association

Associate Professor Rafet Eren is a triple-qualified hematology specialist who received the Young Researcher Award at the 42nd National Hematology Congress.

• Holds a PhD in hematology from Istanbul Training and Research Hospital
• Awarded the title of Associate Professor in hematology after rigorous training
• Treats complex blood cancers at Biruni University Hospital
• Member of the European Society of Hematology
• Published 50 research papers in international medical journals

Associate Professor Mehmet Hilmi Dogu is a leading hematology specialist at Liv Hospital Ulus with deep expertise in managing complex blood cancers. He previously served as the Responsible Authority for the Istanbul Training and Research Hospital Hematology Clinic.

• Specialises in chemotherapy protocols for Hodgkin's and Non-Hodgkin's lymphoma
• Focuses on chronic leukaemia and myeloproliferative diseases like Myelofibrosis
• Board member for the Society of Hematological Education and Research
• Published 32 articles in international peer-reviewed journals on blood disorders
• Completed specialised training at the ESCCA Summer School on Cytometry in Prague

Associate Professor Ali Hakan Kaya is an award-winning haematology specialist at Biruni University Hospital with multiple first-place honours for his clinical research.

• Trained at the Ankara Oncology Training and Research Hospital haematology and stem cell clinic
• Recognised for clinical excellence by the Blood and Bone Marrow Transplantation Association
• Active member of the Turkish Apheresis Society and Hematologic Oncology Society
• Specialises in managing chemotherapy protocols for complex blood cancers and bone marrow disorders

Professor Itir Sirinoglu Temiz is a highly credentialed haematology specialist who leads the internal medicine department at Liv Hospital Vadistanbul.

• Specialises in chemotherapy protocols for lymphoma, myeloma, and complex leukemias
• Expertise in stem cell transplantation and therapeutic apheresis laboratory management
• Former Head of Internal Medicine at Istanbul Aydin University
• Graduated with honours from the prestigious Istanbul University Cerrahpasa Faculty of Medicine
• Member of the Turkish Society of Haematology

Professor Osman Ilhan was part of the pioneering team that performed the first bone marrow stem cell transplant in Turkey. He currently leads haematology services at Private Koru Ankara Hospital after five decades at Ankara University.

• Trained at the MD Anderson Cancer Center in the USA in stem cell mobilisation
• Holds more than 300 publications in PubMed with over 5,000 citations
• Founding president of the Geriatric Hematology Association
• Received the Platinum CME certificate from the European Hematology Association
• Specialises in treating acute and chronic leukaemia, lymphoma, and multiple myeloma

Associate Professor Emrah Eraslan is a senior medical oncologist at Koru Ankara Hospital specializing in complex chemotherapy protocols for solid tumours.

• Trained at the Ankara Oncology Education and Research Hospital – one of Turkey's premier specialised cancer centres
• Achieved academic rank of Associate Professor following extensive research and clinical practice
• Maintains a clinical focus on gastrointestinal cancers, including stomach and colorectal cases
• Manages targeted systemic therapies for breast, prostate, and lung cancer patients
• Highly published researcher contributing to international medical oncology literature

The doctor specializes in various urological conditions, with a focus on penis prosthesis, bladder cancer, prostate cancer, and kidney cancer, including radical and partial nephrectomy. Expertise extends to laparoscopic urology, kidney stones, and surgeries for urinary incontinence in women. The doctor is also skilled in hypospadias surgery, pediatric vesicoureteral reflux, microsurgical varicocele surgery, penis enlargement, and Peyronie's disease correction.

Having completed a urology residency at Istanbul University School of Medicine, the doctor gained extensive experience at Haseki Education and Research Hospital, Bezmialem Vakıf University, Medical Park Bahçelievler, and Ethica Incirli Hospital, and currently serves as a Professor of Medicine at Medicana Hospital Bahcelievler.